The cardiac mapping market size has grown strongly in recent years. It will grow from $2.47 billion in 2025 to $2.65 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing prevalence of atrial fibrillation, expansion of electrophysiology labs, growing adoption of catheter-based interventions, improved availability of cardiac mapping systems, rising demand for minimally invasive procedures.
The cardiac mapping market size is expected to see strong growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing integration of ai-assisted mapping algorithms, expansion of complex arrhythmia treatment, growing investment in electrophysiology infrastructure, rising demand for precision-guided ablation, increasing adoption of advanced visualization platforms. Major trends in the forecast period include increasing adoption of 3D cardiac mapping systems, rising use of real-time electrophysiology mapping, growing integration of mapping with ablation procedures, expansion of non-contact mapping technologies, enhanced focus on procedural accuracy.
The increasing prevalence of heart conditions is anticipated to drive the growth of the cardiac mapping market in the coming years. Heart conditions encompass a range of disorders that impact the structure and function of the heart, resulting in complications such as arrhythmias, heart attacks, and heart failure. The rise in heart conditions is linked to factors like sedentary lifestyles, unhealthy eating habits, and aging populations. Cardiac mapping aids in the diagnosis and treatment of heart conditions by accurately detecting electrical irregularities in the heart's rhythm. For example, in August 2025, the National Institutes of Health, a US-based government agency, reported that between 2025 and 2050, cardiovascular prevalence is expected to increase by 90%, mortality by 73%, and DALYs by 55%, with deaths rising from 20.5 million to 35.6 million. Consequently, the growing prevalence of heart conditions is fueling the expansion of the cardiac mapping market.
Major companies in the cardiac mapping market are concentrating on developing advanced solutions such as pulsed field ablation to enhance the precision, safety, and effectiveness of cardiac arrhythmia treatments. Pulsed Field Ablation (PFA) is a non-thermal cardiac ablation technique that employs high-voltage, short electrical pulses to create microscopic pores in heart tissue cells (electroporation), selectively eliminating abnormal cardiac cells that cause arrhythmias while reducing damage to surrounding healthy tissue. For example, in October 2024, Medtronic Plc, an Ireland-based technology company, received FDA approval for the Affera™ Mapping and Ablation System along with the Sphere-9 Catheter. This system is an all-in-one, high-density mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter designed for the treatment of persistent atrial fibrillation (AFib) and cavotricuspid isthmus (CTI) dependent atrial flutter.
In November 2024, Boston Scientific Corporation, a US-based provider of medical devices and electrophysiology solutions, acquired Cortex, Inc. for an undisclosed sum. Through this acquisition, Boston Scientific intends to incorporate Cortex’s OptiMap electrographic-flow mapping technology to strengthen its cardiac-mapping capabilities, particularly for complex atrial fibrillation (AF) cases. Cortex, Inc. is a US-based company that develops advanced cardiac mapping systems, including the OptiMap system for more precise localization of arrhythmia sources.
Major companies operating in the cardiac mapping market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., GE Healthcare Technologies, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Lepu Medical Technology Co. Ltd., Acutus Medical Inc., Kardium Inc., BioSig Technologies Inc., Catheter Precision Inc., EP Solutions SA, CoreMap Inc., Navix Medical Ltd., EPmap-System, Stereotaxis Inc., CathVision ApS, Baylis Medical Company Inc.
North America was the largest region in the cardiac mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac mapping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cardiac mapping market by increasing costs of imported catheters, electrodes, imaging components, software systems, and precision electronics used in mapping and ablation platforms. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end electrophysiology equipment, while Asia-Pacific faces higher system acquisition costs. These tariffs are elevating capital expenditure requirements and delaying technology upgrades. However, they are also encouraging regional manufacturing, localized software development, and increased innovation in cost-optimized cardiac mapping solutions.
The cardiac mapping market research report is one of a series of new reports that provides cardiac mapping market statistics, including cardiac mapping industry global market size, regional shares, competitors with a cardiac mapping market share, detailed cardiac mapping market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac mapping industry. This cardiac mapping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiac mapping refers to the process of creating a detailed representation of the electrical activity within the heart. It helps identify abnormal heart rhythms (arrhythmias) by mapping the location and patterns of electrical impulses. This information is crucial for diagnosing and treating various cardiac conditions and guiding procedures such as ablation therapy to correct irregular heartbeats.
The main types of cardiac mapping are contact cardiac mapping systems and non-contact cardiac mapping systems. Contact cardiac mapping systems refer to devices that use electrodes in direct contact with the heart tissue to precisely identify and map electrical activity for diagnosing and treating arrhythmias. These systems are indicated for conditions such as atrial fibrillation, atrial flutter, atrioventricular nodal reentrant tachycardia (AVNRT), and others. End users include hospitals and clinics, diagnostic centers, and other healthcare facilities.
The cardiac mapping market consists of revenues earned by entities by providing services such as monitoring and follow-up, diagnostic mapping, and ablation guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac mapping market also includes sales of electrophysiology mapping systems, mapping software, navigation systems, and ablation catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cardiac mapping market size is expected to see strong growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing integration of ai-assisted mapping algorithms, expansion of complex arrhythmia treatment, growing investment in electrophysiology infrastructure, rising demand for precision-guided ablation, increasing adoption of advanced visualization platforms. Major trends in the forecast period include increasing adoption of 3D cardiac mapping systems, rising use of real-time electrophysiology mapping, growing integration of mapping with ablation procedures, expansion of non-contact mapping technologies, enhanced focus on procedural accuracy.
The increasing prevalence of heart conditions is anticipated to drive the growth of the cardiac mapping market in the coming years. Heart conditions encompass a range of disorders that impact the structure and function of the heart, resulting in complications such as arrhythmias, heart attacks, and heart failure. The rise in heart conditions is linked to factors like sedentary lifestyles, unhealthy eating habits, and aging populations. Cardiac mapping aids in the diagnosis and treatment of heart conditions by accurately detecting electrical irregularities in the heart's rhythm. For example, in August 2025, the National Institutes of Health, a US-based government agency, reported that between 2025 and 2050, cardiovascular prevalence is expected to increase by 90%, mortality by 73%, and DALYs by 55%, with deaths rising from 20.5 million to 35.6 million. Consequently, the growing prevalence of heart conditions is fueling the expansion of the cardiac mapping market.
Major companies in the cardiac mapping market are concentrating on developing advanced solutions such as pulsed field ablation to enhance the precision, safety, and effectiveness of cardiac arrhythmia treatments. Pulsed Field Ablation (PFA) is a non-thermal cardiac ablation technique that employs high-voltage, short electrical pulses to create microscopic pores in heart tissue cells (electroporation), selectively eliminating abnormal cardiac cells that cause arrhythmias while reducing damage to surrounding healthy tissue. For example, in October 2024, Medtronic Plc, an Ireland-based technology company, received FDA approval for the Affera™ Mapping and Ablation System along with the Sphere-9 Catheter. This system is an all-in-one, high-density mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter designed for the treatment of persistent atrial fibrillation (AFib) and cavotricuspid isthmus (CTI) dependent atrial flutter.
In November 2024, Boston Scientific Corporation, a US-based provider of medical devices and electrophysiology solutions, acquired Cortex, Inc. for an undisclosed sum. Through this acquisition, Boston Scientific intends to incorporate Cortex’s OptiMap electrographic-flow mapping technology to strengthen its cardiac-mapping capabilities, particularly for complex atrial fibrillation (AF) cases. Cortex, Inc. is a US-based company that develops advanced cardiac mapping systems, including the OptiMap system for more precise localization of arrhythmia sources.
Major companies operating in the cardiac mapping market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., GE Healthcare Technologies, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Lepu Medical Technology Co. Ltd., Acutus Medical Inc., Kardium Inc., BioSig Technologies Inc., Catheter Precision Inc., EP Solutions SA, CoreMap Inc., Navix Medical Ltd., EPmap-System, Stereotaxis Inc., CathVision ApS, Baylis Medical Company Inc.
North America was the largest region in the cardiac mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac mapping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cardiac mapping market by increasing costs of imported catheters, electrodes, imaging components, software systems, and precision electronics used in mapping and ablation platforms. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end electrophysiology equipment, while Asia-Pacific faces higher system acquisition costs. These tariffs are elevating capital expenditure requirements and delaying technology upgrades. However, they are also encouraging regional manufacturing, localized software development, and increased innovation in cost-optimized cardiac mapping solutions.
The cardiac mapping market research report is one of a series of new reports that provides cardiac mapping market statistics, including cardiac mapping industry global market size, regional shares, competitors with a cardiac mapping market share, detailed cardiac mapping market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac mapping industry. This cardiac mapping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiac mapping refers to the process of creating a detailed representation of the electrical activity within the heart. It helps identify abnormal heart rhythms (arrhythmias) by mapping the location and patterns of electrical impulses. This information is crucial for diagnosing and treating various cardiac conditions and guiding procedures such as ablation therapy to correct irregular heartbeats.
The main types of cardiac mapping are contact cardiac mapping systems and non-contact cardiac mapping systems. Contact cardiac mapping systems refer to devices that use electrodes in direct contact with the heart tissue to precisely identify and map electrical activity for diagnosing and treating arrhythmias. These systems are indicated for conditions such as atrial fibrillation, atrial flutter, atrioventricular nodal reentrant tachycardia (AVNRT), and others. End users include hospitals and clinics, diagnostic centers, and other healthcare facilities.
The cardiac mapping market consists of revenues earned by entities by providing services such as monitoring and follow-up, diagnostic mapping, and ablation guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac mapping market also includes sales of electrophysiology mapping systems, mapping software, navigation systems, and ablation catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cardiac Mapping Market Characteristics
3. Cardiac Mapping Market Supply Chain Analysis
4. Global Cardiac Mapping Market Trends and Strategies
5. Cardiac Mapping Market Analysis of End Use Industries
7. Global Cardiac Mapping Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cardiac Mapping Total Addressable Market (TAM) Analysis for the Market
9. Cardiac Mapping Market Segmentation
10. Cardiac Mapping Market Regional and Country Analysis
11. Asia-Pacific Cardiac Mapping Market
12. China Cardiac Mapping Market
13. India Cardiac Mapping Market
14. Japan Cardiac Mapping Market
15. Australia Cardiac Mapping Market
16. Indonesia Cardiac Mapping Market
17. South Korea Cardiac Mapping Market
18. Taiwan Cardiac Mapping Market
19. South East Asia Cardiac Mapping Market
20. Western Europe Cardiac Mapping Market
21. UK Cardiac Mapping Market
22. Germany Cardiac Mapping Market
23. France Cardiac Mapping Market
24. Italy Cardiac Mapping Market
25. Spain Cardiac Mapping Market
26. Eastern Europe Cardiac Mapping Market
27. Russia Cardiac Mapping Market
28. North America Cardiac Mapping Market
29. USA Cardiac Mapping Market
30. Canada Cardiac Mapping Market
31. South America Cardiac Mapping Market
32. Brazil Cardiac Mapping Market
33. Middle East Cardiac Mapping Market
34. Africa Cardiac Mapping Market
36. Cardiac Mapping Market Competitive Landscape and Company Profiles
37. Cardiac Mapping Market Other Major and Innovative Companies
40. Cardiac Mapping Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Cardiac Mapping Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cardiac mapping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiac mapping? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac mapping market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Contact Cardiac Mapping Systems; Non-Contact Cardiac Mapping Systems2) By Indications: Atrial Fibrillation; Atrial Flutter; Atrioventricular Nodal Reentrant Tachycardia (AVNRT); Other Indications
3) By End-User: Hospitals And Clinics; Diagnostic Centers
Subsegments:
1) By Contact Cardiac Mapping Systems: Electrode-Based Mapping Systems; Catheter-Based Mapping Systems; Integrated Mapping And Ablation Systems; 3D Mapping Systems2) By Non-Contact Cardiac Mapping Systems: Non-Contact Voltage Mapping Systems; Electrocardiographic Mapping Systems
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Koninklijke Philips N.V.; GE Healthcare Technologies; BIOTRONIK SE & Co. KG; MicroPort Scientific Corporation; Lepu Medical Technology Co. Ltd.; Acutus Medical Inc.; Kardium Inc.; BioSig Technologies Inc.; Catheter Precision Inc.; EP Solutions SA; CoreMap Inc.; Navix Medical Ltd.; EPmap-System; Stereotaxis Inc.; CathVision ApS; Baylis Medical Company Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cardiac Mapping market report include:- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- GE Healthcare Technologies
- BIOTRONIK SE & Co. KG
- MicroPort Scientific Corporation
- Lepu Medical Technology Co. Ltd.
- Acutus Medical Inc.
- Kardium Inc.
- BioSig Technologies Inc.
- Catheter Precision Inc.
- EP Solutions SA
- CoreMap Inc.
- Navix Medical Ltd.
- EPmap-System
- Stereotaxis Inc.
- CathVision ApS
- Baylis Medical Company Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.65 Billion |
| Forecasted Market Value ( USD | $ 3.4 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
